WO2013070079A8 - miRNA IN BLOOD BRAIN BARRIER OF MS PATIENTS - Google Patents
miRNA IN BLOOD BRAIN BARRIER OF MS PATIENTS Download PDFInfo
- Publication number
- WO2013070079A8 WO2013070079A8 PCT/NL2012/050793 NL2012050793W WO2013070079A8 WO 2013070079 A8 WO2013070079 A8 WO 2013070079A8 NL 2012050793 W NL2012050793 W NL 2012050793W WO 2013070079 A8 WO2013070079 A8 WO 2013070079A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- brain barrier
- blood
- patients
- mirna
- blood brain
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Abstract
The blood-brain barrier (BBB) separates the blood and the central nervous system (CNS). Here it is disclosed that blood-brain barrier function can be increased with particular nucleic acid sequences, in particular in patients suffering from or diagnosed with Multiple Sclerosis. The use of compounds comprising such nucleic acid sequences for increasing blood-brain barrier function is described.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL2007767 | 2011-11-10 | ||
NL2007767 | 2011-11-10 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2013070079A2 WO2013070079A2 (en) | 2013-05-16 |
WO2013070079A3 WO2013070079A3 (en) | 2013-07-11 |
WO2013070079A8 true WO2013070079A8 (en) | 2013-10-24 |
Family
ID=47278967
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/NL2012/050793 WO2013070079A2 (en) | 2011-11-10 | 2012-11-09 | miRNA IN BLOOD BRAIN BARRIER OF MS PATIENTS |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2013070079A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018228875A1 (en) * | 2017-06-15 | 2018-12-20 | Nestec S.A. | Micro-rna biomarkers of blood-brain barrier dysfunction |
KR102177130B1 (en) | 2017-08-18 | 2020-11-10 | (주)큐라미스 | Use of miR-18b for preventing, treating or diagnosing muscular disease and neuromuscular disease |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2977452A3 (en) * | 2007-05-11 | 2016-05-25 | Thomas Jefferson University | Methods of treatment and prevention of neurodegenerative diseases and disorders |
US20100278810A1 (en) | 2007-05-24 | 2010-11-04 | Frank Kuhnert | Methods of Modulating Angiogenesis |
WO2008154644A1 (en) * | 2007-06-12 | 2008-12-18 | Case Western Reserve University | Targeted cell death |
WO2009047362A2 (en) * | 2007-10-12 | 2009-04-16 | The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth, Near Dublin | Method for opening tight junctions |
EP2611918A1 (en) * | 2010-05-28 | 2013-07-10 | Vereniging Voor Christelijk Hoger Onderwijs, Weten | Mirnas involved in the blood brain barrier function |
-
2012
- 2012-11-09 WO PCT/NL2012/050793 patent/WO2013070079A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2013070079A2 (en) | 2013-05-16 |
WO2013070079A3 (en) | 2013-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2011149354A8 (en) | Mirnas involved in the blood brain barrier function | |
MY172292A (en) | Vectors and sequences for the treatment of diseases | |
WO2014124087A8 (en) | Induced pluripotent cell-derived oligodendrocyte progenitor cells for the treatment of myelin disorders | |
WO2014089209A3 (en) | Blood-brain barrier (bbb) penetrating dual specific binding proteins | |
WO2012125987A3 (en) | Delivery system | |
WO2012177603A3 (en) | Metalloenzyme inhibitor compounds | |
WO2012106407A3 (en) | Diagnostic and therapeutic methods and products related to anxiety disorders | |
WO2011041584A3 (en) | Methods for modulation of autophagy through the modulation of autophagy-enhancing gene products | |
WO2011133875A3 (en) | Metalloenzyme inhibitor compounds | |
WO2009090639A3 (en) | Sirna compounds and methods of use thereof | |
WO2011142970A3 (en) | Her2 nucleic acid aptamers | |
WO2012064943A3 (en) | Metalloenzyme inhibitor compounds | |
WO2011022357A3 (en) | Fast acting snare-cleaving enzymes | |
WO2012166626A8 (en) | Reagents and methods for treating dental disease | |
WO2013018060A3 (en) | Micro-rnas and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone- associated medical conditions | |
WO2012065102A8 (en) | S-t-butyl protected cysteine di-peptide analogs and related compounds | |
WO2012027558A3 (en) | OPTIMIZED miRNA CONSTRUCTS | |
WO2013055385A3 (en) | Methods of treating age related disorders | |
EP2750606A4 (en) | Methods for the diagnosis and treatment of neurological and neurodegenerative diseases, disorders and associated processes | |
AU2012240222A8 (en) | Methods of treating central nervous system tumors | |
WO2011163566A3 (en) | Methods of treating patients with immune-related diseases | |
WO2012058529A3 (en) | Metalloenzyme inhibitor compounds | |
WO2011130426A3 (en) | Compositions and methods for treatment of melanoma | |
WO2013072933A3 (en) | Process for preparation of 2-acetamido-n-benzyl-3-methoxypropionamide | |
WO2015069883A8 (en) | Oxidized fraction of extracellular dna as a biomarker of stress and methods for using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12795102 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
122 | Ep: pct app. not ent. europ. phase |
Ref document number: 12795102 Country of ref document: EP Kind code of ref document: A2 |